Supplemental material
Report
Defining the right diluent for intravenous infusion of therapeutic antibodies
, , 
, , &
Tao WangOffice of Biotechnology Products; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USAhttps://orcid.org/0000-0002-1153-3430
https://orcid.org/0000-0002-1153-3430, Silvia M. BacotOffice of Biotechnology Products; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USAhttps://orcid.org/0000-0001-6099-317X
https://orcid.org/0000-0001-6099-317X, Gerald M. FeldmanOffice of Biotechnology Products; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USAhttps://orcid.org/0000-0001-7805-8702
https://orcid.org/0000-0001-7805-8702 & Related Research Data
Dextrose-mediated aggregation of therapeutic monoclonal antibodies in human plasma: Implication of isoelectric precipitation of complement proteins
Source:
Informa UK Limited
Drug streaming during intra-arterial chemotherapy.
Source:
Journal of Neurosurgery Publishing Group (JNSPG)
Building better monoclonal antibody-based therapeutics.
Source:
Springer Science and Business Media LLC
Mixing studies during intracarotid artery infusions in an in vitro model.
Source:
Journal of Neurosurgery Publishing Group (JNSPG)
History of passive antibody administration for prevention and treatment of infectious diseases.
Source:
Ovid Technologies (Wolters Kluwer Health)
Prediction of Aggregation In Vivo by Studies of Therapeutic Proteins in Human Plasma
Source:
Springer New York
PROTEIN PRECIPITATION TECHNIQUES
Source:
Elsevier
Impact of Precipitation of Antibody Therapeutics After Subcutaneous Injection on Pharmacokinetics and Immunogenicity.
Source:
Elsevier BV
Linking provided by
